Discussing Soft Mist Inhaler Technology with Marcel Baumann (World Vaccine Conference 2023)

The partnership aims to develop and commercialize a novel checkpoint inhibitor for immuno-oncology applications.

In this episode of the Drug Solutions Podcast, Jan Bekker, Vice President of Business Development, Commercial and Technical Operations at BioCina, discusses the latest analytical tools and their applications in the drug development market.

This model is being positioned by Shilpa as a dual approach that offers comprehensive discovery, clinical, and commercial outsourcing services in addition to commercially ready, “off-the-shelf” novel formulations for b2b licensing.

An mRNA conversation about the recent past, current hot topics, and probable future.

Sterimove will make its North American debut at the April 1–3, 2025 event.

The investment is intended for the Halo Pharma facility in Whippany, NJ, and aims to help relieve capacity shortages in the injectable supply chain in the United States.